dobutaminecarboplatinpaclitaxelnorepinephrinecarboplatin-onlypaclitaxel-onlyTakotsubo syndromeFood and Drug Administration Adverse Event Reporting System
…agents showed the highest reporting disproportionality, notably dobutamine (reporting OR (ROR) (95% CI) 283.83 (226.55 to 355.60)) and nor…